Find out the 4 FDA decisions to watch in November 2026 for pediatric care.
|Articles|February 10, 2022
5 takeaways from 2021 Issue & Attitudes Survey
Author(s)Miranda Hester
Here are 5 important takeaways from the annual survey.
Advertisement
In the fall of 2021, Contemporary Pediatrics fielded its annual survey to take the temperature on the practice of pediatrics and what's on the mind of clinicians. Here are 5 important takeaways from the results.
Advertisement
Related to this article
Michael Pistiner, MD, discusses how pediatricians can support food allergy management in schools through accurate diagnosis, emergency plans, and education.
Cenobamate sNDAs target PGTC seizures in patients ≥12 years and pediatric focal seizures; phase 3 PGTC data showed a 71.9% median reduction.
Natalie D. Muth, MD, MPH, RDN, MBA, discusses new dietary guidelines, dairy recommendations, processed foods, and nutrition access for children.
FDA approved Lupin's generic of Firdapse for LEMS in patients 6 years and older, but a patent settlement delays US marketing until at least 2035.
Jon Matthew Farber, MD, shares his thoughts on vitamin B12 and the risk of enuresis.
CDC confirmed the first pediatric flu death of 2026-27, linked to H1N1, as early flu activity rises in 2026.
Learn how to distinguish true ADHD from anxiety, trauma, sleep issues, or substance use by tracing symptoms back to childhood across settings and impairment.
Advertisement
Advertisement